Chemoembolization 2

Monday, April 13, 2026

3:00 PM - 4:30 PM ET

Location: 718A

Moderator(s)

Paula Novelli, MD, FSIR (she/her/hers)

Associate Professor of Radiology
University of Pittsburgh Medical Center, Interventional Radiology Division, United States
AB

Amy Bezold

Presentations:

3:00 PM - 3:09 PM ET

Impact of Metabolic Syndrome on Outcomes in Patients with Neuroendocrine Tumor Liver Metastases Treated with Liver Directed Therapy
Presenting Author: Isaac T. Freichels – Medical College of Wisconsin
Author/Co-author: Matthew Henry, MD, MS (he/him/his) – Medical College of Wisconsin
Author/Co-author: Helena Zaldivar Alcantara, MD – Medical College Of Wisconsin
Author/Co-author: William S. Rilling, MD, FSIR – Medical College of Wisconsin
Author/Co-author: Eric J. Hohenwalter, MD, FSIR – Medical College of Wisconsin
Author/Co-author: Sarah B. White, MD, FACR, FSIR, MS – Froedtert & Medical College of Wisconsin
3:09 PM - 3:18 PM ET

Ten-year Survival Outcomes After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma in the Era of Cone-beam CT and Advanced Microcatheter Technology
Presenting Author: Lyo Min Kwon, MD (she/her/hers) – Hallym University Sacred Heart Hospital
Author/Co-author: Jin Wook Chung, MD, PhD – Seoul National University Hospital
3:18 PM - 3:27 PM ET

Embolization of Neuroendocrine Tumor Metastases to the Liver: A Single Center Experience Before and After Introduction of Pressure Enabled Drug Delivery
Presenting Author: Adam Robinson, MS (he/him/his) – Tulane University
Author/Co-author: Richard Marshall, MD – Tulane University
Author/Co-author: Sarena Matriano Lim, MD – Tulane University
Author/Co-author: Annik Irving, BS – Tulane University
Author/Co-author: Chad Hall, BS – Tulane University
3:27 PM - 3:36 PM ET

Longitudinal Monitoring of GRIm and HCC-GRIm Scores Reveals Immunologically Relevant Prognostic Indicators in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs
Presenting Author: Xiaoli Zhu, MD, PhD – The First Affiliated Hospital of Soochow University
Author/Co-author: lihao Qin, MD – The first affiliated hospital of soochow university
3:36 PM - 3:45 PM ET

Efficacy and Cost-Effectiveness of Atezolizumab-Bevacizumab vs Sintilimab-Bevacizumab with TACE in uHCC
Presenting Author: Xiaoli Zhu, MD, PhD – The First Affiliated Hospital of Soochow University
Author/Co-author: Chenyou Liu, MD, MS – The first affiliated hospital of soochow university
3:45 PM - 3:54 PM ET

Multi-Dimensional Vision Transformer Modeling of Lipiodol Staining for Outcome Prediction Following TACE in Hepatocellular Carcinoma
Presenting Author: Tej I. Mehta, MD (he/him/his) – Johns Hopkins Hospital
Author/Co-author: Tony Tae Kyung Kim, MD – Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital
Author/Co-author: Alec Jost, MD – Johns Hopkins Hospital
Author/Co-author: Carolina Lugo-Fagundo, MD – Johns Hopkins University
Author/Co-author: Kent Reichel, MD – Johns Hopkins Hosptial
Author/Co-author: Robert P. Liddell, MD, FSIR – The Johns Hopkins Hospital, Baltimore, Maryland, United States
3:54 PM - 4:03 PM ET

Radiomics-Based Machine Learning to Predict Post-TACE Outcomes Using Lipiodol Staining Patterns in Hepatocellular Carcinoma
Presenting Author: Tej I. Mehta, MD (he/him/his) – Johns Hopkins Hospital
Author/Co-author: Caleb Heiberger, MD – Johns Hopkins
Author/Co-author: Ritam Chowdhury, PhD, MBBS, MPH, MS (he/him/his) – Johns Hopkins
Author/Co-author: Kunaal Bafna, MD – Johns Hopkins University School of Medicine
Author/Co-author: Robert P. Liddell, MD, FSIR – The Johns Hopkins Hospital, Baltimore, Maryland, United States